Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02709512
Title Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (ATOMIC)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Polaris Group

malignant pleural mesothelioma


Cisplatin + Pemetrexed Disodium

ADI-PEG 20 + Cisplatin + Pemetrexed Disodium

Age Groups: adult | senior
Covered Countries USA | ITA

No variant requirements are available.